Iovance Biotherapeutics
IOVA
$13.45
Share price
0.45%
Change (1 day)
82.74%
Change (1 year)
Categories
Iovance Biotherapeutics (IOVA) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to Iovance Biotherapeutics
's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Iovance Biotherapeutics - Cash on Hand chart (from 2008 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -40.69% |
| 2022-12-31 | $0.47 B | -6.46% |
| 2021-12-31 | $0.50 B | -19.86% |
| 2020-12-31 | $0.62 B | 104.97% |
| 2019-12-31 | $0.30 B | -34.46% |
| 2018-12-31 | $0.46 B | 222.29% |
| 2017-12-31 | $0.14 B | -12.67% |
| 2016-12-31 | $0.16 B | 60.53% |
| 2015-12-31 | $0.10 B | 130.91% |
| 2014-12-31 | $44.9 M | 128.29% |
| 2013-12-31 | $19.67 M | |
| 2012-12-31 | $N/A | -100% |
| 2011-12-31 | $0.51 M | -60.68% |
| 2010-12-31 | $1.29 M | 15333.2% |
| 2009-12-31 | $0 M | 189.4% |
| 2008-12-31 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.95% | Bahamas |
 NRC Health
NRC | $6.65 M | -97.62% | 🇺🇸 USA |